<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Nankai_Composite_Part skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Nankai/Composite Part</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Medigo Blue, free responsive template</TITLE></P><DIV class="responsive_menu"><UL class="main_menu"><LI><A href="https://2015.igem.org/Team:Nankai">Home</A></LI><LI><A href="#">Research &amp; Lab</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Description">Project</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Safety">Safety</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Measurement">Measurements</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Parts">Parts</A></LI></UL><LI><A href="#">Member</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Collaborations">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices">Human Practices</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Modeling">Modeling</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices/iShare" target="_blank">iShare</A></LI></DIV><HEADER class="site-header"><DIV><DIV><DIV><DIV class="main-navigation"><NAV class="main-nav visible-md visible-lg"><UL class="sf-menu"><LI id="sideli"><A href="https://2015.igem.org/Team:Nankai/Practices/iShare" target="_blank">iShare</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Modeling">Modeling</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Practices">Human Practices</A></LI><LI><A href="#">Member</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Collaborations">Collaborations</A></LI></UL><LI><A href="#">Research &amp; Lab</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Description">Project</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Safety">Safety</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Measurement">Measurements</A></LI><LI><A href="https://2015.igem.org/Team:Nankai/Parts">Parts</A></LI><LI><A href="https://2015.igem.org/Team:Nankai">Home</A></LI></NAV><DIV class="hidemenu"><P><A href="#">menu</A></P></DIV></DIV></DIV></DIV></DIV></HEADER><DIV class="first-widget parallax" id="blog"><DIV class="parallax-overlay"><P>Your place: <A href="https://2015.igem.org/Team:Nankai">Home</A> &gt; <A href="https://2015.igem.org/Team:Nankai/Parts">Parts</A> &gt; <A href="https://2015.igem.org/Team:Nankai/Composite_Part">Composite Part</A></P><DIV class="container pageTitle"><DIV class="row"><DIV class="col-md-6 col-sm-6"><H2 class="page-title">Composite Parts</H2></DIV></DIV></DIV></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-8 blog-posts"><H4>Composite Parts</H4><P style="position: relative; top: 0px; left: 20px; width: 700px; font-size: 18px; font-family: calibri,Arial, Helvetica, sans-serif; text-align: justify; line-height: 30px;">Promoter P<SUB>xyl</SUB> together with promoter P<SUB>lacI</SUB>, repressor LacI (<A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1628201">BBa_K1628201</A>), promoter P<SUB>grac</SUB> (<A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1628202">BBa_K1628202</A>) and repressor XylR (<A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1628203">BBa_K1628203</A>) formed a metabolic toggle switch.   Promoter P<SUB>xyl</SUB>(<A href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1628002">BBa_K1628002</A>) is a promoter of xylose operon regulate by repressor XylR. Promoter P<SUB>lacI</SUB> is a promoter of lactose operon and LacI is a repressor of lactose operon regulating promoter P<SUB>lacI</SUB>. PlacI is the native promoter of LacI. Promoter P<SUB>grac</SUB> is a promoter of lactose operon regulated by repressor LacI. </P><P style="position: relative; top: 0px; left: 20px; width: 700px; font-size: 18px; font-family: calibri,Arial, Helvetica, sans-serif; text-align: justify; line-height: 30px;">We used this device to regulate the expression of <EM>odhAB</EM> genes in <EM>B. amyloliquefaciens</EM> NK-1 (showed in Figure 1). Without IPTG, the promoter P<SUB>grac</SUB> is inhibited by suppressor LacI and the supreessor XylR will not synthesized, thus the promoter P<SUB>xyl</SUB> is active and <EM>odhAB</EM> genes are expressed. When IPTG is added, the<EM> xylR</EM> gene is expressed and the suppressor XylR is synthesized thereafter inhibited the expression of <EM>odhAB</EM> genes.</P><H6>Figure 1. Metabolic toggle switch to regulate the expression of <EM>odhAB</EM></H6><P style="position: relative; top: 0px; left: 20px; width: 700px; font-size: 18px; font-family: calibri,Arial, Helvetica, sans-serif; text-align: justify; line-height: 30px;">We transformed the plasmids pHT01-<EM>xylR</EM> and pCB-Pxyl into the NK-1  strain, to verify the activity of metabolic toggle switch (see it on our wiki).  Fresh colonies of <EM>Bacillus amyloliquefaciens</EM> strains (NK-1 strain containing plasmids pHT01-xylR and pCB-Pxyl and the  control NK-1 strain containing plasmids pHT01 and pCB-Pxyl) were first cultured  overnight in test tubes containing 5 mL LB liquid and then inoculated into 100  mL fresh fermentation medium. We added 1mM IPTG into the medium after 12h of  cultivation. The β-galactosidase activity were measured at 12h, 18h, 24h, 30h,  36h, 42h to test the effect of metabolic toggle switch on the expression of <EM>bgaB</EM>.
As shown in Figure 2,  β-galactosidase enzyme activity dropped considerably after 30 hours of  fermentation. The inhibited expression of <EM>bgsB </EM>in experiment group (NPP+IPTG) indicated that the metabolic toggle switch  we constructed is functional in <EM>B.  amyloliquefaciens</EM> NK-1 strain.</P><H6>Figure 2. Verification of the metabolic toggle switch’s function. IPTG was added to the medium after 12h cultivation.</H6></DIV><DIV class="col-md-4"><DIV class="sidebar"><DIV class="sidebar-widget"><H6><A href="https://2015.igem.org/Team:Nankai/Parts">Team Parts</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Basic_Part">Basic Parts</A></H6><H6><A href="https://2015.igem.org/Team:Nankai/Composite_Part">Composite Parts</A></H6></DIV><DIV class="sidebar-widget"><P> </P><P> </P><P> </P></DIV></DIV></DIV></DIV></DIV><TITLE>Medigo Blue, free responsive template</TITLE><FOOTER class="site-footer"><DIV class="copyright-content"><DIV class="copyright-text"><P>Copyright © Nankai University </P><P> Nankai IGEM Team 2015</P></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></BODY></HTML>